BLOOD REAGENTS DIRECT PURCHASER ANTITRUST SETTLEMENT OPPORTUNITY
WHAT IS THIS SETTLEMENT ABOUT?
The Plaintiffs in the lawsuit claim that Defendants violated federal antitrust law, as a result of Defendants’ alleged conduct, the prices paid by individuals and entities for Traditional Blood Reagents were higher than they otherwise would have been.
HOW MUCH SETTLEMENT MONEY IS AVAILABLE?
WHO ARE THE DEFENDANTS?
Immucor, Inc. (“Immucor”) and Ortho-Clinical Diagnostics, Inc. (“Ortho”).
WHAT ARE BLOOD REAGENTS?
“Blood Reagents” are products designed and manufactured to test, match, detect, screen, diagnose and/or otherwise identify certain properties of the cell and serum components of human blood. “Traditional Blood Reagents” are primarily used to test blood manually in test tubes. In contrast, proprietary blood reagents are primarily used to test blood in automated and/or semi-automated platforms.
Proprietary reagents sold by Defendants include, but are not limited to, Ortho’s ID-MTS gel products and Immucor’s Capture products.
For purposes of this litigation, the definition of Traditional Blood Reagents does not include Ortho’s 0.8% red blood cell reagents and the certified class includes purchases of only Traditional Blood Reagents; the certified class does not include purchases of proprietary blood reagents and/or Ortho’s 0.8% red blood cell reagents.
IS YOUR COMPANY ELIGIBLE FOR THE SETTLEMENT?
Your company is likely eligible if you purchased Traditional Blood Reagents in the United States directly from either of the Defendants, Ortho or Immucor, during the period from November 4, 2000 through October 19, 2015.
Even if you meet these requirements, you are not a member of the Class if you are a federal governmental entity, a Defendant, or a Defendant’s parent, subsidiary, or affiliate.
Class Action Capital’s fee is a percentage of your financial recovery. You do not have to hire a third-party claims specialist and are entitled to file your claim on your own without incurring any fee. Additional settlement information can be found on the official court approved website www.bloodreagentsantitrustlitigation.com.